Project Grant K23NS138708
- This federal Project Grant award of $220,244 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research conducted by a neurocritical care neurologist at the University of Pennsylvania (Penn) aimed at identifying a novel brain network, termed the Arousal-Awareness Integration Network (AAIN), which may be associated with consciousness...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (CFDA 93.853) provides funding to Yale University to conduct research on using portable magnetic resonance imaging (MRI) to identify hypoxic ischemic brain injury in cardiac arrest patients. The $251,313 award, with a period of performance from August 1, 2025 to July 31, 2027, will support the development of an observational cohort to evaluate the use of low-field portable MRI as a biomarker for...
- This federal Project Grant award, valued at $492,749.00 and awarded by the National Institute of Neurological Disorders and Stroke (NINDS), supports the development of a novel non-invasive magnetic resonance imaging (MRI) technique called ratiometric dual contrast (RDUAL) pH-weighted MRI. The goal is to create an imaging tool that can accurately map the ischemic penumbra (tissue at risk of infarction) and evaluate the risk of reperfusion injury in acute ischemic stroke patients. This research,...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $135,000 Project Grant titled "The NeuroCity Initiative: Empowering Underrepresented Scholars to Pursue Careers in Neuroscience" (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the University of Rochester. This 5-year grant aims to provide an immersive research and mentoring experience, a rigorous career development program, and continuous research and mentoring...
- This Project Grant award of $438,625.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research at the University of California, San Diego (UCSD) to characterize and augment a novel pro-survival mechanism in neurons during ischemic brain injury. The research aims to investigate the role of the protein INF2 in driving "actinification", a...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $630,982 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on "Noninvasive Optical Assessment of Neuroprotection in Deep Hypothermic Circulatory Arrest Procedures". The award period runs from May 6, 2025 to February 28, 2030....
- This Project Grant award of $704,313 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders, aims to advance a prognostic and monitoring biomarker of neutrophil-driven secondary brain injury in spontaneous intracerebral hemorrhage. The primary objective is to define and validate a standardized protocol to detect specific neutrophil biomarker levels as a potential prognostic and...
- This federal Project Grant award, titled "Neurologic-Informed Care to Improve Health Equity Among Persons with Brain Injury Experiencing Homelessness: A Community-Engaged Implementation Approach", is provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The $238,888 award supports research to enhance the delivery of evidence-based...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $571,404.00 to the University of Pittsburgh to conduct research on the use of the adipokine hormone adiponectin as a potential therapy to promote functional recovery after traumatic brain injury (TBI). The funding will support investigations into the long-term impact and...
- This $691,935 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders supports research to develop quantitative diffusion MRI methods for predicting neurodevelopmental outcomes in infants with hypoxic ischemic brain injury. The project aims to analyze diffusion MRI data from two large datasets - the High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL)...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides funding of $224,265 to the University of Pittsburgh to conduct research aimed at improving prognostication for patients with hypoxic-ischemic brain injury following sudden cardiac arrest. The project seeks to use principles of decision science and organizational behavior to develop and test targeted interventions to enhance the accuracy of neurological prognostication in this patient population. The award will support the career development of the principal investigator to refine expertise in decision sciences, organizational behavior, innovative clinical trial design, and social determinants of decision-making. The project leverages the strength of an outstanding mentorship team and the university's robust research infrastructure to advance understanding and address critical knowledge gaps in this important area of neuroscience research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $224.3k | 7/30/25 |